CytRx Corporation announced that it has appointed Dr. Louis Ignarro succeeded Steven A. Kriegsman as Chairman of the Board of Directors on January 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +1.75% | -13.88% | +123.08% |
May. 15 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 27 | LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+123.08% | 1.44M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- Cytrx Corporation Announces Changes to its Board